Open access · CC-BY
via OpenAlex
Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
Jakub Mesinovic, Ayse Zengin, Barbora Vozarova de Courten, Peter Robert Ebeling, David S. Scott
Diabetes Metabolic Syndrome and Obesity · 2019 · ▲ 554 citations
Abstract
The incidence and prevalence of metabolic and musculoskeletal diseases are increasing. Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance, inflammation, advanced glycation end-product accumulation and increased oxidative stress. These characteristics can negatively affect various aspects of muscle health, including muscle mass, strength, quality and function through impairments in protein metabolism, vascular and mitochondrial dysfunction(definition), and cell death. Sarcopenia is a term used to describe the age-related loss in skeletal muscle mass and function and has been implicated as both a cause and consequence of T2DM. Sarcopenia may contribute to the development and progression of T2DM through altered glucose disposal due to low muscle mass, and also increased localized inflammation, which can arise through inter- and intramuscular adipose tissue accumulation. Lifestyle modifications are important for improving and maintaining mobility and metabolic health in individuals with T2DM and sarcopenia. However, evidence for the most effective and feasible exercise and dietary interventions in this population is lacking. In this review, we discuss the current literature highlighting the bidirectional relationship between T2DM and sarcopenia, highlight current research gaps and treatments, and provide recommendations for future research.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2147/dmso.s186600
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Mesinovic, J., Zengin, A., Courten, B.V.D., Ebeling, P.R., & Scott, D.S. (2019). Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. <em>Diabetes Metabolic Syndrome and Obesity</em>. https://doi.org/10.2147/dmso.s186600
Vancouver
Mesinovic J, Zengin A, Courten BVD, Ebeling PR, Scott DS. Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diabetes Metabolic Syndrome and Obesity. 2019. doi:10.2147/dmso.s186600.
BibTeX
@article{jakub2019Sarcop,
title = {Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship},
author = {Jakub Mesinovic and Ayse Zengin and Barbora Vozarova de Courten and Peter Robert Ebeling and David S. Scott},
journal = {Diabetes Metabolic Syndrome and Obesity},
year = {2019},
doi = {10.2147/dmso.s186600},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Communications 2019
Open access · CC-BY
Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities
Dionyssiotis, Yannis, M.D. 2018
Open access · US-GOV
Sarcopenia and Diabetes Mellitus
Journal of Diabetes Research 2020
Open access · CC-BY
Metabolic and Nutritional Characteristics in Middle-Aged and Elderly Sarcopenia Patients with Type 2 Diabetes
Sports Medicine 2024
Open access · CC-BY
Mitochondria as Nutritional Targets to Maintain Muscle Health and Physical Function During Ageing
Aging and Disease 2026
Open access · CC-BY
Mitochondrial Inflammation and Muscle Aging: Targeting the Inflammatory Microenvironment in Sarcopenic Muscle
Diabetes Research and Clinical Practice 2018
Citation only